Trials / Completed
CompletedNCT06150547
A Study of Metabolic Agents Following Brain Radiation
Pilot Imaging Study for CNS Metabolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being done to determine if CEST magnetic resonance imaging (MRI) and FDG PET are feasible techniques to detect metabolic differences between tumor and brain in patients with a brain tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | FDG Positron Emission Tomography | Imaging using an FDG radioactive tracer to look at the head. |
| DIAGNOSTIC_TEST | Chemical Exchange Saturation Transfer Magnetic Resonance Imaging | A noninvasive diagnostic test for measuring biochemical changes in the brain, especially the presence of tumors. |
Timeline
- Start date
- 2023-12-27
- Primary completion
- 2025-08-04
- Completion
- 2025-08-04
- First posted
- 2023-11-29
- Last updated
- 2025-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06150547. Inclusion in this directory is not an endorsement.